Labshake search

1101 - 1150 of 3345 citations for Recombinant Human IFNB1 Fc tagged since 2019

• Investigating T cell Recruitment in Atherosclerosis using a novel Human 3D Tissue-Culture Model reveals the role of CXCL12 in intraplaque neovessels

  Laura Parma, et al., bioRxiv - Molecular Biology 2024

  Quote: ... and Human TruStain FcX (Biolegend, Cat. 422301), plaques were stained with primary antibodies directed at CD31 (M0823 ...
• MicroRNA-focused CRISPR/Cas9 Screen Identifies miR-142 as a Key Regulator of Epstein-Barr Virus Reactivation

  Yan Chen, et al., bioRxiv - Molecular Biology 2024

  Quote: ... 100 μL Human TruStain FcX™ (BioLegend) was added ...
• AXL limits the mobilization of cholesterol to regulate dendritic cell maturation and the immunogenic response to cancer

  Meriem Belabed, et al., bioRxiv - Immunology 2023

  Quote: ... anti-human PD-L2 (clone MIH18, BioLegend), anti-human HLA-A,B,C (clone W6/32 ...
• AXL limits the mobilization of cholesterol to regulate dendritic cell maturation and the immunogenic response to cancer

  Meriem Belabed, et al., bioRxiv - Immunology 2023

  Quote: ... anti-human PD-L1 (clone 29E2A3, BioLegend), anti-human PD-L2 (clone MIH18 ...
• Tuft cells act as regenerative stem cells in the human intestine

  Lulu Huang, et al., bioRxiv - Cell Biology 2024

  Quote: ... or Biotin anti-human CD117 (Biolegend, 313208) and Brilliant Violet 421™ Streptavidin (Biolegend ...
• Tuft cells act as regenerative stem cells in the human intestine

  Lulu Huang, et al., bioRxiv - Cell Biology 2024

  Quote: ... APC/Cy7 anti- human CD45 (Biolegend, 304014), PE anti-human CD117 antibody (KIT ...
• CAR-engineered lymphocyte persistence is governed by a FAS ligand/FAS auto-regulatory circuit

  Fei Yi, et al., bioRxiv - Immunology 2024

  Quote: ... Human TrueStain FcX blocking solution (Biolegend, 422302) was added to cells for 10 min before staining ...
• T cell polarization and NFAT translocation are stiffness-dependent and are differentially regulated by Piezo1 and Orai1

  Renping Zhao, et al., bioRxiv - Immunology 2024

  Quote: ... Biotin anti-human CD28 Antibody (BioLegend, 302904), Alexa Fluor® 647 anti-Tubulin-α Antibody (BioLegend ...
• T cell polarization and NFAT translocation are stiffness-dependent and are differentially regulated by Piezo1 and Orai1

  Renping Zhao, et al., bioRxiv - Immunology 2024

  Quote: ... Biotin anti-human CD3 Antibody (BioLegend, 317320), Biotin anti-human CD28 Antibody (BioLegend ...
• AXL limits the mobilization of cholesterol to regulate dendritic cell maturation and the immunogenic response to cancer

  Meriem Belabed, et al., bioRxiv - Immunology 2023

  Quote: ... anti-human CD206 (clone 15-2, BioLegend), anti-human CD80 (clone W17149D ...
• Combining Cell-Intrinsic and -Extrinsic Resistance to HIV-1 By Engineering Hematopoietic Stem Cells for CCR5 Knockout and B Cell Secretion of Therapeutic Antibodies

  William N. Feist, et al., bioRxiv - Bioengineering 2024

  Quote: ... anti-human HLA-ABC (Biolegend, cat. 311426), anti-human CD33 (BD ...
• Perivascular cells function as mechano-structural sensors of vascular capillaries

  Cristiane M. Franca, et al., bioRxiv - Bioengineering 2024

  Quote: ... APC/Cyanine7 anti-human CD90 (5E10, BioLegend), PE-Cy™5 Mouse Anti-Human CD235a (HIR2 ...
• Cancer-associated fibroblasts produce matrix-bound vesicles that influence endothelial cell function

  Alice Santi, et al., bioRxiv - Cancer Biology 2023

  Quote: ... and human TruStain FcXTM (1/200, BioLegend) for 45min on ice (100 μl/106 cells) ...
• Folate depletion induces erythroid differentiation through perturbation of de novo purine synthesis

  Adam G. Maynard, et al., bioRxiv - Molecular Biology 2022

  Quote: ... Transferrin receptor (human) (1:200; BioLegend, 334108).
• HIV-1 infection of genetically engineered iPSC-derived central nervous system-engrafted microglia in a humanized mouse model

  Alice K. Min, et al., bioRxiv - Neuroscience 2023

  Quote: ... CD45 (anti-human Alexa Fluor 700, Biolegend), CD206 (anti-human BV785 ...
• HIV-1 infection of genetically engineered iPSC-derived central nervous system-engrafted microglia in a humanized mouse model

  Alice K. Min, et al., bioRxiv - Neuroscience 2023

  Quote: ... and CD8 (anti-human PerCP-Cy5.5, Biolegend) for 30min at 4°C ...
• The CARD8 inflammasome drives CD4⁺ T-cell depletion in HIV-1 infection

  Qiankun Wang, Liang Shan, bioRxiv - Microbiology 2023

  Quote: ... anti-human CCR7-Alexa 647 (BioLegend #353218), anti-p24-PE (Beckman Coulter #KC57-RD1) ...
• Therapeutic Prime/Pull Vaccination of HSV-2 Infected Guinea Pigs with the Ribonucleotide Reductase 2 (RR2) Protein and CXCL11 Chemokine Boosts Antiviral Local Tissue-Resident and Effector Memory CD4⁺ and CD8⁺ T Cells and Protects Against Recurrent Genital Herpes

  Afshana Quadiri, et al., bioRxiv - Immunology 2023

  Quote: ... anti-mouse/human CD44 (clone IM7, Biolegend), anti-mouse CD69 (clone H1.2F3 ...
• Caspase-2 is essential for proliferation and self-renewal of nucleophosmin-mutated acute myeloid leukemia

  Dharaniya Sakthivel, et al., bioRxiv - Cancer Biology 2023

  Quote: ... APC anti-human CD14 (clone 63D3; BioLegend). Alexa Fluor 647 Phalloidin was purchased from Cell Signaling Technology ...
• Solid tumor-on-chip model for efficacy and safety assessment of CAR-T cell therapy

  Tengku Ibrahim Maulana, et al., bioRxiv - Bioengineering 2023

  Quote: ... anti-human CD4 APC/Fire750 (357426; BioLegend), anti-human CD8a PerCP (300922 ...
• Depletion of alloreactive B cells by chimeric alloantigen receptor T cells with drug resistance to prevent antibody-mediated rejection in solid organ transplantation

  Anna C. Dragon, et al., bioRxiv - Immunology 2023

  Quote: ... the LEGENDplex human CD8/NK Panel (BioLegend) was performed according to the manufacturer’s instructions ...
• Macrophage Migration Inhibitory Factor on Apoptotic Extracellular Vesicles Regulates Compensatory Proliferation

  Safia A. Essien, et al., bioRxiv - Cell Biology 2023

  Quote: ... The Human Anti-CD74 antibody (BioLegend, 326802) was stored at 4°C ...
• Vascularised Cardiac Spheroids-on-a-Chip for Testing the Toxicity of Therapeutics

  Stefania Di Cio, et al., bioRxiv - Bioengineering 2023

  Quote: ... APC anti- human CD140b (PDGFRβ, Biolegend 323608); Alexa Fluor 488 anti-fibronectin (eBioscience™) ...
• Therapeutic immune cell engineering with an mRNA : AAV-Sleeping Beauty composite system

  Lupeng Ye, et al., bioRxiv - Bioengineering 2023

  Quote: ... and 200U/mL human IL-2 (BioLegend).
• Therapeutic immune cell engineering with an mRNA : AAV-Sleeping Beauty composite system

  Lupeng Ye, et al., bioRxiv - Bioengineering 2023

  Quote: ... 20ng/mL of human GM-CSF (BioLegend) was used to differentiate monocytes into macrophages for 7 days ...
• Cancer-associated fibroblasts produce matrix-bound vesicles that influence endothelial cell function

  Alice Santi, et al., bioRxiv - Cancer Biology 2023

  Quote: ... and human TruStain FcXTM (1/200, BioLegend) in 100 μl of FACS buffer for 45min on ice ...
• Cancer-associated fibroblasts produce matrix-bound vesicles that influence endothelial cell function

  Alice Santi, et al., bioRxiv - Cancer Biology 2023

  Quote: ... and human TruStain FcXTM (1/200, BioLegend) in 100 μl of FACS buffer for 45min on ice ...
• T-cell derived extracellular vesicles prime macrophages for improved STING based cancer immunotherapy

  Aida S. Hansen, et al., bioRxiv - Immunology 2023

  Quote: ... or human IgG1 (clone MOPC-21) (Biolegend) for 30 min ...
• Engineered cytokine/antibody fusion proteins improve delivery of IL-2 to pro-inflammatory cells and promote antitumor activity

  Elissa K. Leonard, et al., bioRxiv - Bioengineering 2023

  Quote: ... BV605 anti-human CD8 (clone SK1, Biolegend); BV421 anti-human CD25 (clone M-A251 ...
• Co-engagement of TIGIT⁺ immune cells to PD-L1⁺ tumours by a bispecific antibody potentiates T-cell response and tumour control

  Xiaopei Cui, et al., bioRxiv - Immunology 2023

  Quote: ... APC/CY7 anti human CD16 (Biolegend/302017), FITC anti human CD107a antibodies (Biolegend/328606 ...
• Co-engagement of TIGIT⁺ immune cells to PD-L1⁺ tumours by a bispecific antibody potentiates T-cell response and tumour control

  Xiaopei Cui, et al., bioRxiv - Immunology 2023

  Quote: ... PE/CY7 anti-human TIGIT (Biolegend/372714). Binding of anti-TIGIT antibodies HB0036/HB0030 to cell surface was detected by APC-anti his (Biolegend/362605) ...
• Luminal epithelial cells integrate variable responses to aging into stereotypical changes that underlie breast cancer susceptibility

  Rosalyn W. Sayaman, et al., bioRxiv - Cancer Biology 2022

  Quote: ... or anti-human CD133-PE (BioLegend, clone7), and anti-human CD271-APC (BioLegend ...
• Therapeutic immune cell engineering with an mRNA : AAV-Sleeping Beauty composite system

  Lupeng Ye, et al., bioRxiv - Bioengineering 2023

  Quote: ... and 400U/mL human IL-2 (BioLegend). T cells were activated with Dynabeads Human T-Activator CD3/CD28 (ThermoFisher ...
• Carcinoma-associated fibroblast-like tumor cells remodel the Ewing sarcoma tumor microenvironment

  Emma D. Wrenn, et al., bioRxiv - Cancer Biology 2023

  Quote: ... 2.5 μL human TruStain FcX (BioLegend #42230) was added per sample and incubated at 4°C for 10 minutes ...
• Metabolic Reprogramming via targeting ACOD1 promotes polarization and anti-tumor activity of human CAR-iMACs in solid tumors

  Xudong Wang, et al., bioRxiv - Immunology 2023

  Quote: ... FITC Human IgG1 Isotype Control (403507, Biolegend), APC anti-human CD206 (321109 ...
• Gut microbiota and maternal immune transfer at birth influence pre-allergic clinical outcome

  Remy Villette, et al., bioRxiv - Immunology 2023

  Quote: ... anti-human IgE PerCP-Cy5.5 (Biolegend, BLE325512) and human Fc biotin (009-060-008) ...
• Metabolic Reprogramming via targeting ACOD1 promotes polarization and anti-tumor activity of human CAR-iMACs in solid tumors

  Xudong Wang, et al., bioRxiv - Immunology 2023

  Quote: ... APC Human IgG1 Isotype Control (403505, Biolegend), FITC Human IgG1 Isotype Control (403507 ...
• Validation of ligand tetramers for the detection of antigen-specific lymphocytes

  Kristin S. Fitzpatrick, et al., bioRxiv - Immunology 2022

  Quote: ... anti-human HLA-ABC (W6/32, BioLegend), and anti-mouse H-2Kb (Y3 ...
• B-Cell Precursor Acute Lymphoblastic Leukemia elicits an Interferon-α/β response in Bone Marrow-derived Mesenchymal Stroma

  Mandy W. E. Smeets, et al., bioRxiv - Cancer Biology 2023

  Quote: ... PE anti-human CD4 and CD56 (Biolegend), Brilliant violet (BV)421 anti-human CD8 (Biolegend) ...
• The CARD8 inflammasome drives CD4⁺ T-cell depletion in HIV-1 infection

  Qiankun Wang, Liang Shan, bioRxiv - Microbiology 2023

  Quote: ... anti-human CD45-Pacific Blue (BioLegend # 304029), anti-human CD3-BV650 (BioLegend # 317324) ...
• Co-engagement of TIGIT⁺ immune cells to PD-L1⁺ tumours by a bispecific antibody potentiates T-cell response and tumour control

  Xiaopei Cui, et al., bioRxiv - Immunology 2023

  Quote: ... FITC anti human CD107a antibodies (Biolegend/328606) on ice for 30 min and then subjected to FACS analysis (BD/Canto II ...
• Designer small molecule control system based on Minocycline induced disruption of protein-protein interaction

  Ram Jha, et al., bioRxiv - Molecular Biology 2023

  Quote: ... APC anti-human EGFR antibody (Biolegend, 352905), Alexa Fluor® 488 anti-human EGFR antibody (Biolegend ...
• Selective Inhibition of Interleukin-2 Inducible T Cell Kinase (ITK) Enhances Anti-Tumor Immunity in Association with Th1-skewing, Cytotoxic T cell Activation, and Reduced T Cell Exhaustion

  Lih-Yun Hsu, et al., bioRxiv - Cancer Biology 2023

  Quote: ... and anti-human IL-12 (C8.6, Biolegend) neutralizing antibodies (10 mg/ml each ...
• Selective Inhibition of Interleukin-2 Inducible T Cell Kinase (ITK) Enhances Anti-Tumor Immunity in Association with Th1-skewing, Cytotoxic T cell Activation, and Reduced T Cell Exhaustion

  Lih-Yun Hsu, et al., bioRxiv - Cancer Biology 2023

  Quote: ... and anti-human IL-5 (TRFK5, Biolegend)neutralizing antibodies (10 ug/ml each ...
• Fine needle aspiration of human lymph nodes reveals cell populations and soluble interactors pivotal to immunological priming

  Nicholas M. Provine, et al., bioRxiv - Immunology 2023

  Quote: ... TotalSeq-C Human Universal Cocktail V1.0 (BioLegend) was prepared per manufacturer’s instructions and added to the cells without washing ...
• Solid tumor-on-chip model for efficacy and safety assessment of CAR-T cell therapy

  Tengku Ibrahim Maulana, et al., bioRxiv - Bioengineering 2023

  Quote: ... and anti-human CD25 BV421 (302630; BioLegend). Detailed information on the antibodies is summarized in Supplementary Table 2 ...
• Solid tumor-on-chip model for efficacy and safety assessment of CAR-T cell therapy

  Tengku Ibrahim Maulana, et al., bioRxiv - Bioengineering 2023

  Quote: ... anti-human CD3 PE/Cyanine7 (317334; BioLegend), anti-human CD4 APC/Fire750 (357426 ...
• Generation of circulating autoreactive pre-plasma cells fueled by naïve B cells in celiac disease

  Ida Lindeman, et al., bioRxiv - Immunology 2023

  Quote: ... anti-human CD3-BV605 (clone UCHT1, BioLegend), anti-human CD14-BV510 (clone M5E2 ...
• Generation of circulating autoreactive pre-plasma cells fueled by naïve B cells in celiac disease

  Ida Lindeman, et al., bioRxiv - Immunology 2023

  Quote: ... anti-human CD21-APC (clone Bu32, BioLegend), anti-human CD24-BV605 (clone ML5 ...
• Generation of circulating autoreactive pre-plasma cells fueled by naïve B cells in celiac disease

  Ida Lindeman, et al., bioRxiv - Immunology 2023

  Quote: ... anti-human CD14-BV510 (clone M5E2, BioLegend), anti-human CD14-BV605 (clone M5E2 ...